ARS Pharmaceuticals, Inc. (SPRY) Accounts payable

annual accounts payable:

$9.87M+$9.11M(+1200.40%)
December 31, 2024

Summary

  • As of today (September 16, 2025), SPRY annual accounts payable is $9.87 million, with the most recent change of +$9.11 million (+1200.40%) on December 31, 2024.
  • During the last 3 years, SPRY annual accounts payable has risen by +$8.08 million (+452.63%).
  • SPRY annual accounts payable is now at all-time high.

Performance

SPRY Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

quarterly accounts payable:

$15.56M+$11.46M(+279.95%)
June 30, 2025

Summary

  • As of today (September 16, 2025), SPRY quarterly accounts payable is $15.56 million, with the most recent change of +$11.46 million (+279.95%) on June 30, 2025.
  • Over the past year, SPRY quarterly accounts payable has increased by +$12.29 million (+375.52%).
  • SPRY quarterly accounts payable is now at all-time high.

Performance

SPRY quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

SPRY Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+1200.4%+375.5%
3 y3 years+452.6%+636.0%
5 y5 years+180.6%-

SPRY Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+1200.4%at high>+9999.0%
5 y5-yearat high+1200.4%at high>+9999.0%
alltimeall timeat high+1200.4%at high>+9999.0%

SPRY Accounts payable History

DateAnnualQuarterly
Jun 2025
-
$15.56M(+280.0%)
Mar 2025
-
$4.09M(-58.5%)
Dec 2024
$9.87M(+1200.4%)
$9.87M(+19.3%)
Sep 2024
-
$8.28M(+152.9%)
Jun 2024
-
$3.27M(+290.0%)
Mar 2024
-
$839.00K(+10.5%)
Dec 2023
$759.00K(-54.2%)
$759.00K(-74.4%)
Sep 2023
-
$2.97M(+97.6%)
Jun 2023
-
$1.50M(-41.8%)
Mar 2023
-
$2.58M(+1947.6%)
Dec 2022
$1.66M
-
DateAnnualQuarterly
Sep 2022
-
$126.00K(-94.0%)
Jun 2022
-
$2.11M(-19.7%)
Mar 2022
-
$2.63M(+26.6%)
Dec 2021
$1.79M(-30.9%)
-
Dec 2021
-
$2.08M(+20.8%)
Sep 2021
-
$1.72M(-4.7%)
Jun 2021
-
$1.80M(-58.7%)
Mar 2021
-
$4.37M(+69.3%)
Dec 2020
$2.58M(-26.6%)
$2.58M(-26.6%)
Dec 2019
$3.52M(+353.9%)
$3.52M
Dec 2018
$775.00K
-

FAQ

  • What is ARS Pharmaceuticals, Inc. annual accounts payable?
  • What is the all time high annual accounts payable for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. annual accounts payable year-on-year change?
  • What is ARS Pharmaceuticals, Inc. quarterly accounts payable?
  • What is the all time high quarterly accounts payable for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?

What is ARS Pharmaceuticals, Inc. annual accounts payable?

The current annual accounts payable of SPRY is $9.87M

What is the all time high annual accounts payable for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high annual accounts payable is $9.87M

What is ARS Pharmaceuticals, Inc. annual accounts payable year-on-year change?

Over the past year, SPRY annual accounts payable has changed by +$9.11M (+1200.40%)

What is ARS Pharmaceuticals, Inc. quarterly accounts payable?

The current quarterly accounts payable of SPRY is $15.56M

What is the all time high quarterly accounts payable for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high quarterly accounts payable is $15.56M

What is ARS Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?

Over the past year, SPRY quarterly accounts payable has changed by +$12.29M (+375.52%)
On this page